Last reviewed · How we verify

Chirocaine ketorolac epinephrine

maximiliano barahona vasquez · Phase 3 active Small molecule

Chirocaine ketorolac epinephrine is a Local anesthetic combination with NSAID and vasopressor Small molecule drug developed by maximiliano barahona vasquez. It is currently in Phase 3 development for Local anesthesia and hemostasis during surgical procedures, Perioperative pain management.

This combination drug provides local anesthesia via chirocaine, reduces inflammation and pain via ketorolac, and enhances vasoconstriction and hemostasis via epinephrine.

This combination drug provides local anesthesia via chirocaine, reduces inflammation and pain via ketorolac, and enhances vasoconstriction and hemostasis via epinephrine. Used for Local anesthesia and hemostasis during surgical procedures, Perioperative pain management.

At a glance

Generic nameChirocaine ketorolac epinephrine
Sponsormaximiliano barahona vasquez
Drug classLocal anesthetic combination with NSAID and vasopressor
TargetVoltage-gated sodium channels (chirocaine); COX-1/COX-2 (ketorolac); alpha-1 and beta-adrenergic receptors (epinephrine)
ModalitySmall molecule
Therapeutic areaPain Management, Surgery, Anesthesia
PhasePhase 3

Mechanism of action

Chirocaine (levobupivacaine) is a local anesthetic that blocks sodium channels in nerve fibers. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin-mediated pain and inflammation. Epinephrine acts as an alpha and beta-adrenergic agonist to cause vasoconstriction, reducing bleeding and prolonging the duration of local anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Chirocaine ketorolac epinephrine

What is Chirocaine ketorolac epinephrine?

Chirocaine ketorolac epinephrine is a Local anesthetic combination with NSAID and vasopressor drug developed by maximiliano barahona vasquez, indicated for Local anesthesia and hemostasis during surgical procedures, Perioperative pain management.

How does Chirocaine ketorolac epinephrine work?

This combination drug provides local anesthesia via chirocaine, reduces inflammation and pain via ketorolac, and enhances vasoconstriction and hemostasis via epinephrine.

What is Chirocaine ketorolac epinephrine used for?

Chirocaine ketorolac epinephrine is indicated for Local anesthesia and hemostasis during surgical procedures, Perioperative pain management.

Who makes Chirocaine ketorolac epinephrine?

Chirocaine ketorolac epinephrine is developed by maximiliano barahona vasquez (see full maximiliano barahona vasquez pipeline at /company/maximiliano-barahona-vasquez).

What drug class is Chirocaine ketorolac epinephrine in?

Chirocaine ketorolac epinephrine belongs to the Local anesthetic combination with NSAID and vasopressor class. See all Local anesthetic combination with NSAID and vasopressor drugs at /class/local-anesthetic-combination-with-nsaid-and-vasopressor.

What development phase is Chirocaine ketorolac epinephrine in?

Chirocaine ketorolac epinephrine is in Phase 3.

What are the side effects of Chirocaine ketorolac epinephrine?

Common side effects of Chirocaine ketorolac epinephrine include Hypertension, Tachycardia, Gastrointestinal bleeding or ulceration (ketorolac-related), Renal impairment (ketorolac-related), Local tissue irritation or necrosis, Allergic reaction.

What does Chirocaine ketorolac epinephrine target?

Chirocaine ketorolac epinephrine targets Voltage-gated sodium channels (chirocaine); COX-1/COX-2 (ketorolac); alpha-1 and beta-adrenergic receptors (epinephrine) and is a Local anesthetic combination with NSAID and vasopressor.

Related